Literature DB >> 26805754

Health Status and Morbidities in Resident Relatives of Patients With COPD.

Nienke Nakken1, Martijn A Spruit2, Esther H A van den Bogaart2, Monique van Vliet3, Geeuwke J de Vries4, Frank L Custers3, Jan H Vercoulen5, Guus M Asijee6, Jean W Muris7, Lowie E G W Vanfleteren2, Frits M E Franssen2, Emiel F M Wouters8, Daisy J A Janssen9.   

Abstract

OBJECTIVES: Resident relatives of patients with chronic obstructive pulmonary disease (COPD) may play a major role in obtaining a healthy lifestyle for patients. Little is known about resident relatives. This study aimed to compare health status, morbidities, care dependency, and mobility between patients with COPD and their resident relatives.
DESIGN: Cross-sectional study. PARTICIPANTS: Stable patients with moderate to very severe COPD (n = 194) and their resident relatives (n = 194) were visited in their home environment. MEASUREMENTS: Post-bronchodilator spirometry was assessed and generic health status was measured using the EuroQol-5 Dimensions and the Assessment of Quality of Life with 8 dimensions. Care dependency was measured using the Care Dependency Scale. Mobility was measured using the Timed "Up and Go" test (TUG). Morbidities (COPD, hypertension, anxiety and depression, obesity, and muscle wasting) were determined using accepted disease cutoff points and/or receiving specific treatment.
RESULTS: Age (patients: 66.0 [8.7], resident relatives: 64.8 [9.7]) and gender (male patients: 53%, male resident relatives: 45%) were comparable. Patients had worse generic health status, higher level of care dependency, and worse mobility. 29% of the resident relatives had airflow limitation based on the Tiffeneau index and 19% based on the lower limit of normal, 33% were current smokers, and 92% had at least one chronic condition. Resident relatives more frequently had hypertension (46% versus 69%).
CONCLUSION: Resident relatives of patients with COPD are often current smokers and often have undiagnosed morbidities. Although their health status is better compared with patients, their disease management and health behavior should also be considered when advising patients in obtaining a healthier lifestyle and also when involving them as informal caregivers.
Copyright © 2016 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Relative; chronic obstructive pulmonary disease; health status; informal caregiver; morbidity

Mesh:

Year:  2016        PMID: 26805754     DOI: 10.1016/j.jamda.2015.12.012

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  4 in total

1.  Gender differences in partners of patients with COPD and their perceptions about the patients.

Authors:  Nienke Nakken; Daisy Ja Janssen; Monique van Vliet; Geeuwke J de Vries; Giny Al Clappers-Gielen; Arent Jan Michels; Jean Wm Muris; Jan H Vercoulen; Emiel Fm Wouters; Martijn A Spruit
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-23

2.  Knowledge gaps in patients with COPD and their proxies.

Authors:  Nienke Nakken; Daisy J A Janssen; Esther H A van den Bogaart; Jean W M Muris; Jan H Vercoulen; Frank L Custers; Gerben P Bootsma; Michiel H M Gronenschild; Emiel F M Wouters; Martijn A Spruit
Journal:  BMC Pulm Med       Date:  2017-10-30       Impact factor: 3.317

3.  The physical, mental, and social impact of COPD in a population-based sample: results from the Longitudinal Aging Study Amsterdam.

Authors:  Frits M E Franssen; Dionne E Smid; Dorly J H Deeg; Martijn Huisman; Jan Poppelaars; Emiel F M Wouters; Martijn A Spruit
Journal:  NPJ Prim Care Respir Med       Date:  2018-08-10       Impact factor: 2.871

4.  Care Dependency in Non-Hospitalized Patients with COVID-19.

Authors:  Anouk W Vaes; Felipe V C Machado; Roy Meys; Jeannet M Delbressine; Yvonne M J Goertz; Maarten Van Herck; Sarah Houben-Wilke; Frits M E Franssen; Herman Vijlbrief; Yvonne Spies; Alex J Van 't Hul; Chris Burtin; Daisy J A Janssen; Martijn A Spruit
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.